Latest Articles
Endocrine disruptors may increase the risk of endometrial cancer - ibsgranada.es
Endocrine disruptors may increase the risk of endometrial cancer ibsgranada.es
Published: Feb. 28, 2024, 8 a.m.
Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients - Nature.com
Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients Nature.com
Published: Feb. 22, 2024, 8 a.m.
FDA Grants Priority Review to Pembrolizumab/Chemo in Endometrial Cancer - Cancer Network
FDA Grants Priority Review to Pembrolizumab/Chemo in Endometrial Cancer Cancer Network
Published: Feb. 20, 2024, 8 a.m.
Early Warnings: Harnessing machine learning insights to improve endometrial cancer diagnosis - Carle Health
Early Warnings: Harnessing machine learning insights to improve endometrial cancer diagnosis Carle Health
Published: Feb. 13, 2024, 8 a.m.
The causal effects of genetically predicted alcohol consumption on endometrial cancer risk from a Mendelian randomization study | Scientific Reports - Nature.com
The causal effects of genetically predicted alcohol consumption on endometrial cancer risk from a Mendelian randomization study | Scientific Reports Nature.com
Published: Feb. 12, 2024, 8 a.m.
Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R-Ca - Wiley Online Library
Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R-Ca Wiley Online Library
Published: Feb. 11, 2024, 8 a.m.
FDA Approves GSK's Jemperli For Expanded Use In Endometrial Cancer - Contract Pharma
FDA Approves GSK's Jemperli For Expanded Use In Endometrial Cancer Contract Pharma
Published: Feb. 8, 2024, 8 a.m.
HER2 ADCs in Endometrial Cancer: Shaping the Treatment Landscape - OncLive
HER2 ADCs in Endometrial Cancer: Shaping the Treatment Landscape OncLive
Published: Feb. 1, 2024, 8 a.m.
Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer - OncLive
Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer OncLive
Published: Jan. 26, 2024, 8 a.m.
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer - Nature.com
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer Nature.com
Published: Jan. 17, 2024, 8 a.m.
Link copied to clipboard!